Surgery is still the gold standard for dMMR/MSI-H colon cancer
European Journal of Surgical Oncology · 2026-11 · 112347
DOI: 10.1016/j.ejso.2026.112347 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2026-11. Verfasst von Jérémie H Lefèvre und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Service de Chirurgie Digestive, Hôpital Saint-Antoine, AP-HP, Paris, France. Electronic address: jeremie.lefevre@aphp.fr. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Neoadjuvant immune checkpoint inhibitors (ICI) produce unprecedented pathological responses in localised dMMR/MSI-H colon cancer, and organ preservation is now proposed by analogy with dMMR rectal cancer. This analogy is misleading. Upfront colectomy is a short, safe procedure that cures most patients, since most are stage I-II. Segmental colectomy carries very low morbidity, 5-year overall survival exceeds 85%, and functional impairment or stoma-related issues are almost non-existent. Organ preservation requires around six months of ICI, exposes patients to immune-related toxicity and to obstruction or perforation of the primary tumour, relies on response assessment blind to nodal status, risks inappropriate treatment of a misdiagnosed MSI status, is expensive, and leaves an at-risk colon in Lynch syndrome. Partial colectomy should remain the standard - upfront for most patients, after neoadjuvant ICI for selected cases such as cT4 or tumours at risk of R1 resection - with organ preservation confined to randomised trials.
Autor:innen und Institutionen
- Sorbonne Université, Service de Chirurgie Digestive, Hôpital Saint-Antoine, AP-HP, Paris, France. Electronic address: jeremie.lefevre@aphp.fr.
- Sorbonne Université, Service d'Oncologie Médicale, Hôpital Saint-Antoine, AP-HP, INSERM UMRS 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe Labellisée Par La Ligue Natio…
- Sorbonne Université, Service de Chirurgie Digestive, Hôpital Saint-Antoine, AP-HP, Paris, France.
Zitieren
APA
Lefèvre, J. H., Cohen, R., Parc, Y., & André, T. (2026). Surgery is still the gold standard for dMMR/MSI-H colon cancer. European Journal of Surgical Oncology, 112347. https://doi.org/10.1016/j.ejso.2026.112347
Vancouver
Lefèvre JH, Cohen R, Parc Y, André T. Surgery is still the gold standard for dMMR/MSI-H colon cancer. European Journal of Surgical Oncology. 2026:112347. doi:10.1016/j.ejso.2026.112347
BibTeX
@article{Lefvre2026,
author = {Lefèvre, Jérémie H and Cohen, Romain and Parc, Yann and André, Thierry},
title = {Surgery is still the gold standard for dMMR/MSI-H colon cancer},
journal = {European Journal of Surgical Oncology},
year = {2026},
pages = {112347},
doi = {10.1016/j.ejso.2026.112347}
}
EUVIMED